000 01553 a2200433 4500
005 20250517082120.0
264 0 _c20161107
008 201611s 0 0 eng d
022 _a1464-3405
024 7 _a10.1016/j.bmcl.2016.01.089
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKim, Taelim
245 0 0 _aIdentification of novel estrogen receptor (ER) agonists that have additional and complementary anti-cancer activities via ER-independent mechanism.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cApr 2016
300 _a1844-8 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntineoplastic Agents
_xchemistry
650 0 4 _aBenzophenones
_xchemistry
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aEstrogen Receptor alpha
_xantagonists & inhibitors
650 0 4 _aEstrogens
_xchemistry
650 0 4 _aHumans
650 0 4 _aMolecular Docking Simulation
650 0 4 _aNeoplasms
_xdrug therapy
650 0 4 _aOximes
_xchemistry
700 1 _aKim, Hye-In
700 1 _aAn, Ji-Young
700 1 _aLee, Jun
700 1 _aLee, Na-Rae
700 1 _aHeo, Jinyuk
700 1 _aKim, Ji-Eun
700 1 _aYu, Jihyun
700 1 _aLee, Yong Sup
700 1 _aInn, Kyung-Soo
700 1 _aKim, Nam-Jung
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 26
_gno. 7
_gp. 1844-8
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2016.01.089
_zAvailable from publisher's website
999 _c25760857
_d25760857